The expanding role of pertuzumab in the treatment of HER2-positive breast cancer
I Moya-Horno,1 J Cortés1,2 1Department of Medical Oncology, Instituto Oncológico Baselga, Hospital Quirón, 2Department of Medical Oncology, Vall d'Hebron Institute of Oncology, Barcelona, Spain Abstract: Breast cancer tumors that demonstrate gene amplificatio...
Enregistré dans:
Auteurs principaux: | Moya-Horno I, Cortés J |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2015
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/4330ba2b64314281afb0b2ecbad96dc8 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Role of pertuzumab in the treatment of HER2-positive breast cancer
par: Hubalek M, et autres
Publié: (2012) -
Neratinib plus trastuzumab is superior to pertuzumab plus trastuzumab in HER2-positive breast cancer xenograft models
par: Jamunarani Veeraraghavan, et autres
Publié: (2021) -
Combination of Pertuzumab and Trastuzumab in the Treatment of HER2-Positive Early Breast Cancer: A Review of the Emerging Clinical Data
par: Jagosky M, et autres
Publié: (2021) -
Role of trastuzumab emtansine in the treatment of HER2-positive breast cancer
par: Oostra DR, et autres
Publié: (2014) -
Role of lapatinib alone or in combination in the treatment of HER2-positive breast cancer
par: Hurvitz SA, et autres
Publié: (2012)